A phase I/II trial of Temodar in pediatric patients and young adults with high-risk or recurrent solid tumors

Trial Profile

A phase I/II trial of Temodar in pediatric patients and young adults with high-risk or recurrent solid tumors

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 05 Apr 2007

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top